Login
$ECOR
$7.44 +$0.39 (5.53%) Close

Company Executives

$ECOR Management Team

Dr. Thomas Errico

Independent Chairman of the Board

Age 73
Compensation $169.9K USD
Sex Male

Mr. Daniel Goldberger

Chief Executive Officer

Director

Age 66
Compensation $1.619M USD
Sex Male

Mr. Joshua Lev

Chief Financial Officer

Age 40
Compensation $703.8K USD
Sex Male
Directors
6
serving now
Independent
Not stated
the proxy does not say
Average tenure
8.8 years
from year joined
CEO also chairs the board
No
Thomas J. Errico, M.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Thomas J. Errico, M.D.
74 2005
21 years
Not stated None stated None stated $214,995
James C. Theofilos
31 Not stated Not stated None stated None stated Not stated
Elena Bonfiglioli
54 Not stated Not stated None stated None stated $162,496
John P. Gandolfo
65 2020
6 years
Not stated None stated Oragenics, Inc $174,998
Julie A. Goldstein
67 2022
4 years
Not stated None stated None stated $162,498
Patricia Wilber
64 2022
4 years
Not stated None stated Zapp Electric Vehicles Group Limited $164,998

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

5 disclosed in the proxy filed Jul 20, 2026
Vagus Nerve Society
An executive of the Company co-founded and is President of the Vagus Nerve Society
Amount not stated
2025

Company agreed to provide an unrestricted educational grant to the Vagus Nerve Society and provided educational and directed research grants.

With Vagus Nerve Society Open in proxy
a member of our Board
member of our Board
$3,000
2025

Consulting agreement for consulting and advisory services to the CEO, with hourly or per diem fees and a stock option for 50,000 shares at $6.43 per share.

a former executive
former executive
$4,600
2025

Consulting agreement for financial and accounting consulting services on an hourly basis.

Zhang Tianyi
beneficial owner of greater than 5% of our share capital
Amount not stated
2025

License agreement giving the Chinese company access to develop products based on certain nVNS patents in certain territories, with a 10% royalty to the Company; no royalties received in 2025.

With a Chinese company beneficially owned by Zhang Tianyi Open in proxy
Dan Goldberger
retired from the Company; separation agreement with the Company
Amount not stated
2026

Separation agreement under which he retired, provides advisory and transition services for one year after April 1, 2026, and has a right to invest pari passu in certain equity offerings through August 31, 2028.

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support